Table 4. SR rates in different subgroups divided according to sex, age, disease, and sensitization.
| SRs | SR rates | |||||
|---|---|---|---|---|---|---|
| No. of patients | No. of injections | % of patients | P value | % of injections | P value | |
| Sex (%) | ||||||
| Male | 17 (63) | 28 (58) | 13.28 | 0.870 | 1.05 | 0.728 |
| Female | 10 (37) | 20 (42) | 12.50 | 1.17 | ||
| Age (%) | ||||||
| Children | 24 (89) | 45 (94) | 19.83 | <0.001 | 1.79 | <0.001 |
| Adults | 3 (11) | 3 (6) | 3.45 | 0.16 | ||
| Disease (%) | ||||||
| Asthma | 17 (63) | 34 (71) | 25.00 | <0.001 | 2.20 | <0.001 |
| No asthma | 10 (37) | 14 (29) | 7.14 | 0.50 | ||
| Sensitization status (%) | ||||||
| Mono-sensitized | 20 (74) | 39 (81) | 11.24 | 0.126 | 1.05 | 0.478 |
| Multi-sensitized | 7 (26) | 9 (19) | 23.33 | 1.36 | ||
| SPT (%) | ||||||
| Greatly sensitized | 15 (56) | 28 (58) | 20.00 | 0.024 | 1.71 | 0.003 |
| Not greatly sensitized | 12 (44) | 20 (42) | 9.02 | 0.73 | ||
| Serum sIgE (%) | ||||||
| Greatly sensitized | 26 (96) | 47 (98) | 16.67 | 0.027 | 1.38 | <0.001 |
| Not greatly sensitized | 1 (4) | 1 (2) | 1.92 | 0.10 | ||